These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28657848)

  • 1. Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    Ishikawa T; Aibe Y; Matsuda T; Iwamoto T; Takami T; Sakaida I
    AJR Am J Roentgenol; 2017 Sep; 209(3):W169-W176. PubMed ID: 28657848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.
    Ishikawa T; Shiratsuki S; Matsuda T; Iwamoto T; Takami T; Uchida K; Terai S; Yamasaki T; Sakaida I
    J Gastroenterol; 2014 Sep; 49(9):1333-41. PubMed ID: 24096983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome.
    Yamamoto A; Nishida N; Morikawa H; Jogo A; Kageyama K; Sohgawa E; Hamamoto S; Takeshita T; Sakai Y; Matsuoka T; Kawada N; Miki Y
    J Vasc Interv Radiol; 2016 Aug; 27(8):1160-7. PubMed ID: 27234486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A; Chalamarla LK; Singla N; Shasthry SM; Sarin SK
    Eur Radiol; 2020 Jun; 30(6):3462-3472. PubMed ID: 32048037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.
    Kim SK; Lee KA; Sauk S; Korenblat K
    Korean J Radiol; 2017; 18(2):345-354. PubMed ID: 28246514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.
    Choi YH; Yoon CJ; Park JH; Chung JW; Kwon JW; Choi GM
    Korean J Radiol; 2003; 4(2):109-16. PubMed ID: 12845306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
    Wang YB; Zhang JY; Gong JP; Zhang F; Zhao Y
    J Gastroenterol Hepatol; 2016 Apr; 31(4):727-33. PubMed ID: 26637789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications.
    Saad WE; Kitanosono T; Koizumi J; Hirota S
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):101-51. PubMed ID: 23830671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon-occluded antegrade transvenous obliteration with or without balloon-occluded retrograde transvenous obliteration for the management of gastric varices: concept and technical applications.
    Saad WE; Kitanosono T; Koizumi J
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):203-25. PubMed ID: 23021832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores.
    Saad WE; Wagner CC; Al-Osaimi A; Bliebel W; Lippert A; Davies MG; Sabri SS; Turba UC; Matsumoto AH; Angle JF; Caldwell S
    Vasc Endovascular Surg; 2013 May; 47(4):281-7. PubMed ID: 23681780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices using foam sclerosant and a reduced balloon inflation time: Feasibility and efficacy.
    Clements W; Barrett R; Roberts SK; Majeed A; Kemp W; Moriarty HK
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):490-495. PubMed ID: 32441461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year outcomes of balloon-occluded retrograde transvenous obliteration of gastric varices in liver transplant recipients: A multi-institutional study.
    Saad WE; Chick JFB; Srinivasa RN; Saad N; Kim S; Fischman A; Frey G; Al-Osaimi A; Caldwell S
    Diagn Interv Imaging; 2017 Nov; 98(11):801-808. PubMed ID: 28416166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration.
    Sabri SS; Abi-Jaoudeh N; Swee W; Saad WE; Turba UC; Caldwell SH; Angle JF; Matsumoto AH
    J Vasc Interv Radiol; 2014 Mar; 25(3):355-61. PubMed ID: 24468043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of solitary gastric fundal varices and portosystemic encephalopathy accompanying liver cirrhosis by balloon-occluded retrograde transvenous obliteration (B-RTO): a case report.
    Ohmoto K; Miyake I; Tsuduki M; Ohno S; Yamamoto S
    Hepatogastroenterology; 1999; 46(26):1249-52. PubMed ID: 10370701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts.
    Mukund A; Deogaonkar G; Rajesh S; Shasthry SM; Sarin SK
    Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1010-1016. PubMed ID: 28180928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution.
    Oshita K; Ohira M; Honmyo N; Kobayashi T; Murakami E; Aikata H; Baba Y; Kawano R; Awai K; Chayama K; Ohdan H
    J Gastroenterol; 2020 Sep; 55(9):877-887. PubMed ID: 32533300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balloon-occluded retrograde transvenous obliteration for intractable gastric variceal bleeding.
    Liang TJ; Chen YC; Liang HL; Liu SI; Chang PM
    J Formos Med Assoc; 2013 Jul; 112(7):426-9. PubMed ID: 23927983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.